Pfizer Total investments increased by 5.2% to $1.18B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 14.0%, from $1.37B to $1.18B. Over 4 years (FY 2020 to FY 2024), Total investments shows a downward trend with a -18.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth indicates the successful accumulation of capital and reinvestment of profits or insurance premiums.
The aggregate value of all financial assets held for the purpose of generating income or capital appreciation, including...
Used to compare the investment scale of global insurers and sovereign wealth funds.
fin_total_investments| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.17B | $3.88B | $3.49B | $3.04B | $2.97B | $2.84B | $2.36B | $2.51B | $2.12B | $2.78B | $2.54B | $2.21B | $1.37B | $1.25B | $1.03B | $1.12B | $1.18B |
| QoQ Change | — | -6.9% | -10.1% | -12.8% | -2.3% | -4.6% | -17.0% | +6.5% | -15.5% | +31.2% | -8.5% | -13.1% | -38.1% | -8.9% | -17.3% | +8.4% | +5.2% |
| YoY Change | — | — | — | — | -28.6% | -26.8% | -32.4% | -17.6% | -28.7% | -2.0% | +8.0% | -11.8% | -35.4% | -55.2% | -59.5% | -49.4% | -14.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.